146 related articles for article (PubMed ID: 536259)
1. Comparison of the CCNU and BCNU modification of the in vitro radiation response in 9L brain tumor cells of rats.
Deen DF; Williams ME; Wheeler KT
Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1541-4. PubMed ID: 536259
[No Abstract] [Full Text] [Related]
2. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
Weiss RB; Issell BF
Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
[No Abstract] [Full Text] [Related]
3. Experimental brain tumor chemotherapy: DNA damage in the rat gliosarcoma 9L treated with CCNU.
Gutin PH; Hilton J; Walker MD
Clin Neurosurg; 1977; 24():653-64. PubMed ID: 583703
[No Abstract] [Full Text] [Related]
4. Multidisciplinary treatment for central nervous system tumours with nitrosourea compounds.
Paoletti P; Robustelli della Cuna G; Knerich R; Strada MR
Acta Neurochir (Wien); 1978; 41(4):287-99. PubMed ID: 356524
[TBL] [Abstract][Full Text] [Related]
5. Clinical comparison of the nitrosoureas.
Wasserman TH; Slavik M; Carter SK
Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
[TBL] [Abstract][Full Text] [Related]
6. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
Wong KH; Wallen CA; Wheeler KT
J Neurooncol; 1991 Aug; 11(1):17-25. PubMed ID: 1833513
[TBL] [Abstract][Full Text] [Related]
7. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant nitrosourea therapy for glioblastoma.
Brisman R; Housepian EM; Chang C; Duffy P; Balis E
Arch Neurol; 1976 Nov; 33(11):745-50. PubMed ID: 985152
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole.
Wheeler KT; Wallen CA; Wolf KL; Siemann DW
Br J Cancer; 1984 Jun; 49(6):787-93. PubMed ID: 6733024
[TBL] [Abstract][Full Text] [Related]
10. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.
Solero CL; Monfardini S; Brambilla C; Vaghi A; Valagussa P; Morello G; Bonadonna G
Cancer Clin Trials; 1979; 2(1):43-8. PubMed ID: 229983
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant chemotherapy with nitrosourea compounds following surgery plus radiotherapy in glioblastoma multiforme.
Monfardini S; Brambilla C; Solero CL; Vaghi A; Valagussa P; Morello G; Bonadonna G
Recent Results Cancer Res; 1978; 68():393-8. PubMed ID: 223206
[No Abstract] [Full Text] [Related]
12. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
[TBL] [Abstract][Full Text] [Related]
13. Experiments on the chemotheraphy of a transplantable glioblastoma in the rat, employing 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
Waldbaur H; Kuschnir H; Engelmann U; Schmidt H; Schmack B
Acta Neurochir (Wien); 1978; 42(1-2):103-8. PubMed ID: 696438
[TBL] [Abstract][Full Text] [Related]
14. Single-agent chemotherapy of brain tumors. A five-year review.
Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
[TBL] [Abstract][Full Text] [Related]
15. The effect of phenobarbital on the toxicity and tumoricidal activity of CCNU in a murine brain tumor model.
Muller PJ; Tator CH; Bloom M
J Neurosurg; 1980 Mar; 52(3):359-66. PubMed ID: 7359190
[No Abstract] [Full Text] [Related]
16. Environmental factors modifying the effect of CCNU on glioma in vitro and in vivo.
Maker HS; Syed H; Whetsell W; Lehrer GM
Trans Am Neurol Assoc; 1976; 101():273-5. PubMed ID: 1028258
[No Abstract] [Full Text] [Related]
17. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
Levin VA; Kabra PA; Freeman-Dove MA
Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
[TBL] [Abstract][Full Text] [Related]
18. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
Hansen HH; Selawry OS; Pajak TF; Spurr CL; Falkson G; Brunner K; Cuttner J; Nissen NI; Holland JF
Cancer; 1981 Jan; 47(1):14-8. PubMed ID: 7006789
[TBL] [Abstract][Full Text] [Related]
19. [The effects of combined chemotherapy (adriamycin/VM/26/CCNU) in brian tumours in adults and animal experiments (author's transl)].
Ilsen HW; Petrovici IN; Mennel HD; Zülch KJ; Szymas J
Fortschr Neurol Psychiatr; 1982 Mar; 50(3):73-90. PubMed ID: 7095717
[No Abstract] [Full Text] [Related]
20. Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard.
Evans CG; Bodell WJ; Tokuda K; Doane-Setzer P; Smith MT
Cancer Res; 1987 May; 47(10):2525-30. PubMed ID: 2882834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
